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Reply
To the Editor:
We read the comments by Navarrete-Navarrete et al regarding our article investigating how self-efﬁcacy for pain
control and pain catastrophizing are related to pain, stiffness, fatigue, and psychological distress in patients with
SLE. Navarrete-Navarrete et al directed readers to their
important study regarding the role of high levels of chronic
stress experienced by SLE patients in relevant SLE outcomes (1) as well as an interesting intervention trial in SLE
patients (2).
Navarrete-Navarrete et al conducted a study suggesting
that high levels of daily stress, although not stressful life
events, were associated with an exacerbation of SLE symptoms (1). Subsequently, the authors carried out a randomized controlled trial examining the efﬁcacy of CBT for
coping with chronic stress in patients with SLE (2). In this
trial, 45 patients with SLE and high levels of daily stress
were randomized to either a group receiving 10 consecutive weekly sessions of CBT for coping with chronic stress
or a control group. The authors examined posttreatment
outcomes over the next year and found that participants in
the CBT intervention group reported decreased levels of
depression, anxiety, and daily stress compared to participants in the control group. Participants in the CBT stress
coping intervention group also demonstrated signiﬁcant
improvements in QOL and somatic symptoms including
pain compared to the control group. No differences between the groups were found for immunologic measures.
Our study speciﬁcally examined how the pain coping
cognitions (i.e., self-efﬁcacy for pain control and pain catastrophizing) of the SLE patients were related to physical
symptoms and psychological distress in patients with SLE.
We found that pain coping cognitions were related to pain,
stiffness, fatigue, and mood even after controlling for age,
race, and disease activity. In our article, we suggested that
shifting the treatment of SLE patients from a traditional
approach with medication (e.g., immunosuppressive therapy) to a multidisciplinary approach that includes treatments addressing pain cognitions may have an important
and positive impact on SLE outcomes. The application of
a tailored pain coping skills training (PCST) (3) protocol
that aims to increase self-efﬁcacy for pain control and
decrease pain catastrophizing may be particularly beneﬁcial for these patients.
A PCST protocol tailored for SLE patients would focus
on enhancing the ability of these patients to manage their
pain and decrease their negative pain coping strategies
(i.e., pain catastrophizing). We hypothesize that such a
PCST protocol would result in increased self-efﬁcacy for
pain control, decreased pain catastrophizing, decreased
pain, and increased physical and psychological functioning. The CBT stress coping protocol that targeted decreases
in daily stress that Navarrete-Navarrete et al tested produced signiﬁcant reductions in pain, depression, anxiety,
and daily stress as well as somatic symptoms.
It would be interesting to compare the efﬁcacy of a
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tailored PCST protocol to the CBT-based chronic stress
coping protocol proposed by Navarrete-Navarrete et al (4)
in patients with SLE. Both protocols may be effective for
treating certain physical symptoms and psychological distress, although the degree of improvement may vary; it
remains unknown whether the CBT-based chronic stress
coping protocol would impact important pain coping cognitions. Another important aim of future work would be
to examine how pretreatment individual factors (e.g., age,
disease severity, pain levels, and daily stressors) moderate
the impact of such intervention protocols on important
outcomes. For instance, SLE patients who have high levels
of pain and/or pain catastrophizing but limited levels of
daily stress may beneﬁt most from a PCST protocol, while
SLE patients with low levels of pain catastrophizing but
high levels of daily stress may beneﬁt from a CBT-based
protocol focused on coping with chronic stress. In another
instance, patients with moderate levels of both pain catastrophizing and daily stress may beneﬁt from a combination of these intervention protocols.
We appreciate the interest by Navarrete-Navarrete et al
in our work and their comments. We plan to move forward
by examining CBT-based pain interventions in patients
with SLE and will certainly use their ﬁndings to inform
and advance our future work.
Tamara J. Somers, PhD
Preethi C. Kurakula, MD
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Musculoskeletal ultrasound for enhancing
pediatric rheumatology: comment on the
article by McAlindon et al
To the Editor:
We read with great interest the article by McAlindon et
al published recently in Arthritis Care & Research (1). The
use of musculoskeletal ultrasound (US) has tremendously
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enhanced the ﬁeld of rheumatology in the past 2 decades
(1). Particularly, musculoskeletal US is paramount for
the early diagnosis of various rheumatic diseases and for
the close followup of patients (mainly as an objective
means of outcome assessment) during their lengthy treatment periods (2). Furthermore, musculoskeletal US has
even been included in the diagnostic criteria for rheumatoid arthritis, ankylosing spondylitis, and polymyalgia
rheumatica (3–5).
Musculoskeletal US has some very well-known advantages; it is convenient and inexpensive, it does not contain
radiation, and it readily provides comparative and dynamic imaging with great comfort for the patient and the
physician alike. Additionally, with techniques such as
sonopalpation or sonoauscultation, the role of musculoskeletal US as an extension of the physical examination
(its use in musculoskeletal assessment is much like how
the stethoscope is used in a physical examination) has also
been noted (6 – 8). Also noteworthy is that musculoskeletal
US can provide immediate guidance once the need for any
type of intervention (aspiration/injection) has been determined (9).
In this regard, especially when considering its advantages in terms of radiation exposure (there is none) and
dynamic imaging (the extra procedures required for magnetic resonance imaging in pediatric patients are unnecessary), one would expect musculoskeletal US to be much
more commonly used in pediatric rheumatology; however,
pertinent studies in the literature suggest the contrary (10 –
12). In general, the 2 important barriers against the use of
musculoskeletal US by nonradiologists seem to be the lack
of a device to administer musculoskeletal US and the lack
of education on how to perform it (13). However, based on
our experience organizing the musculoskeletal US workshops in the previous 2 PRES (Pediatric Rheumatology
European Society) fellowship courses in 2009 and 2011,
we believe that the former barrier outweighs the latter. Yet,
parallel courses (for pediatric rheumatologists) are organized in several meetings because we are aware that, although the use of musculoskeletal US in pediatric rheumatology resembles that in adult rheumatology, there are
particular differences/challenges pertaining to pediatric
patients.
In short, we recommend that pediatric rheumatologists
(and possibly of the whole ﬁeld as well) should focus their
attention on the need to expedite the use of musculoskeletal US in pediatric rheumatology. Aside from initial attempts to supply US machines to individual centers, the
immediate agenda should also comprise setting up standardized international approaches to musculoskeletal US
training and assessment for pediatric rheumatologist
sonographers. If the immediate agenda is implemented
this way, we foresee that musculoskeletal US will soon
enhance the actual clinical practice of pediatric rheumatology, from the perspective of both patients and physicians alike.
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